Skip to main content
. 2021 May 17;6(5):e005847. doi: 10.1136/bmjgh-2021-005847

Table 1.

Characteristics of included primary prevalence study reports (n=488) providing data for the period 1987–2017

Variables N (%)*
Study type
 Peer-reviewed 194 (40)
 Report or survey 294 (60)
Region (Global Burden of Disease super regions)
 Central Europe, Eastern Europe and Central Asia 75 (15)
 High Income 300 (61)
 Latin America and Caribbean 27 (6)
 North Africa and Middle East 20 (4)
 South Asia 9 (2)
 Southeast Asia, East Asia and Oceania 25 (5)
 Sub-Saharan Africa 32 (7)
Prevalence
 Any prevalence period 484 (99)
 Unclear prevalence period 4 (1)
 Point prevalence 57 (12)
Incidence 9 (2)
Age groups
 0–4 28 (6)
 5–9 33 (7)
 10–14 214 (44)
 15–19 385 (79)
 20–24 256 (52)
 25–29 264 (54)
 30–34 270 (55)
 35–39 273 (56)
 40–44 281 (58)
 45–49 287 (59)
 50–54 297 (61)
 55–59 294 (60)
 60–64 286 (59)
 65–69 276 (57)
 70–74 268 (55)
 75–79 257 (53)
 80–84 245 (50)
 85–89 243 (50)
 90–94 241 (49)
 95+ 240 (49)
Data for both genders available 472 (97)
Representative sample 446 (91)
Acceptable low back pain definition 79 (16)

*Numbers do not add up to the total number of reports (488) because some reports measured more than one prevalence period.